Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-30 @ 8:08 AM
Study NCT ID:
NCT00954135
Status:
UNKNOWN
Last Update Posted:
2009-08-07
First Post:
2009-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients
Sponsor:
University of Turin, Italy
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EudraCT 2007-006208-39
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Alfredo Berruti
Old Organization:
Dipartimento di Scienze Cliniche e Biologiche Università di Torino